ALK and anaplastic large cell lymphoma: Subsequently, a COG phase II study (ANHL12P1) comparing addition of BV to ALCL99 chemotherapy regiment for newly diagnosed ALK-positive pediatric ALCL found superior relapse prevention in the BV arm compared to conventional chemotherapy alone, without additional toxicity [106].